[{"address1": "Life Science & Technology Park", "address2": "Suite 520 1951 NW 7th Avenue", "city": "Miami", "state": "FL", "zip": "33136", "country": "United States", "phone": "844 470 2550", "website": "https://longeveron.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The company's lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors. It is conducting Phase 1, Phase 1/2, Phase 2a, and Phase 2b clinical trials in various indications, such as aging-related frailty, alzheimer's disease, and hypoplastic left heart syndrome. Longeveron Inc. was incorporated in 2014 and is headquartered in Miami, Florida.", "fullTimeEmployees": 23, "companyOfficers": [{"maxAge": 1, "name": "Dr. Joshua Michael Hare FACC, M.D.", "age": 61, "title": "Co-Founder, Chief Science Officer & Chairman", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 74000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mohamed Wa'el Ahmed Hashad M.B.A.", "age": 62, "title": "CEO & Director", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 867854, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lisa A. Locklear M.B.A.", "age": 62, "title": "Chief Financial Officer", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 472272, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul T. Lehr J.D.", "age": 56, "title": "General Counsel & Secretary", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 554055, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Devin  Blass", "title": "CTO & Senior VP of Chemistry, Manufacturing, and Controls", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Nataliya  Agafonova M.D.", "age": 54, "title": "Chief Medical Officer", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lisa  McClain-Moss", "age": 52, "title": "Vice President of Manufacturing", "yearBorn": 1972, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian G Rash Ph.D.", "title": "VP of Research & Discovery", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Elly  Ryu", "age": 43, "title": "VP & Corporate Controller", "yearBorn": 1981, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Heather  Zhou", "title": "VP & Corporate Controller", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.57, "open": 1.6, "dayLow": 1.6, "dayHigh": 1.71, "regularMarketPreviousClose": 1.57, "regularMarketOpen": 1.6, "regularMarketDayLow": 1.6, "regularMarketDayHigh": 1.71, "beta": 0.346, "forwardPE": -1.0915033, "volume": 189372, "regularMarketVolume": 189372, "averageVolume": 277662, "averageVolume10days": 152590, "averageDailyVolume10Day": 152590, "bid": 1.63, "ask": 1.69, "bidSize": 100, "askSize": 100, "marketCap": 24777456, "fiftyTwoWeekLow": 0.771, "fiftyTwoWeekHigh": 6.4, "priceToSalesTrailing12Months": 13.378756, "fiftyDayAverage": 1.7462, "twoHundredDayAverage": 2.02095, "currency": "USD", "enterpriseValue": 3598414, "floatShares": 11678916, "sharesOutstanding": 13352800, "sharesShort": 586064, "sharesShortPriorMonth": 669305, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.0395, "heldPercentInsiders": 0.10309, "heldPercentInstitutions": 0.08722, "shortRatio": 2.33, "shortPercentOfFloat": 0.045300003, "impliedSharesOutstanding": 14836800, "bookValue": 1.727, "priceToBook": 0.96699476, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -26570000, "trailingEps": -5.62, "forwardEps": -1.53, "lastSplitFactor": "1:10", "lastSplitDate": 1711497600, "enterpriseToRevenue": 1.943, "enterpriseToEbitda": -0.215, "52WeekChange": -0.7009524, "SandP52WeekChange": 0.22903383, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "LGVN", "underlyingSymbol": "LGVN", "shortName": "Longeveron Inc.", "longName": "Longeveron Inc.", "firstTradeDateEpochUtc": 1613140200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "0810e7c7-ed9c-3408-947e-be0c34d084bb", "messageBoardId": "finmb_410711455", "gmtOffSetMilliseconds": -18000000, "currentPrice": 1.67, "targetHighPrice": 10.0, "targetLowPrice": 6.0, "targetMeanPrice": 8.875, "targetMedianPrice": 9.75, "recommendationKey": "none", "numberOfAnalystOpinions": 4, "totalCash": 22778000, "totalCashPerShare": 1.535, "ebitda": -16706000, "totalDebt": 1599000, "quickRatio": 7.47, "currentRatio": 7.667, "totalRevenue": 1852000, "debtToEquity": 6.24, "revenuePerShare": 0.295, "returnOnAssets": -0.53143, "returnOnEquity": -1.11101, "grossProfits": 1352000, "freeCashflow": -9382250, "operatingCashflow": -14492000, "revenueGrowth": 4.153, "grossMargins": 0.73002, "operatingMargins": -6.01423, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-02-15"}]